Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 32

1.

Malignant Rhabdoid Tumor, an Aggressive Tumor Often Misclassified as Small Cell Variant of Hepatoblastoma.

Fazlollahi L, Hsiao SJ, Kochhar M, Mansukhani MM, Yamashiro DJ, Remotti HE.

Cancers (Basel). 2019 Dec 11;11(12). pii: E1992. doi: 10.3390/cancers11121992.

2.

Plasma-thrombin cell blocks: Potential source of DNA contamination.

Sung S, Sireci AN, Remotti HE, Hodel V, Mansukani MM, Fernandes H, Saqi A.

Cancer Cytopathol. 2019 Dec;127(12):771-777. doi: 10.1002/cncy.22203. Epub 2019 Nov 22.

PMID:
31756042
3.

A Therapeutic Silencing RNA Targeting Hepatocyte TAZ Prevents and Reverses Fibrosis in Nonalcoholic Steatohepatitis in Mice.

Wang X, Sommerfeld MR, Jahn-Hofmann K, Cai B, Filliol A, Remotti HE, Schwabe RF, Kannt A, Tabas I.

Hepatol Commun. 2019 Jul 23;3(9):1221-1234. doi: 10.1002/hep4.1405. eCollection 2019 Sep. Erratum in: Hepatol Commun. 2019 Nov 26;4(1):134.

4.

Downregulation of Friend Leukemia Integration 1 (FLI1) follows the stepwise progression to gastric adenocarcinoma.

Del Portillo A, Komissarova EV, Bokhari A, Hills C, de Gonzalez AK, Kongkarnka S, Remotti HE, Sepulveda JL, Sepulveda AR.

Oncotarget. 2019 Jun 11;10(39):3852-3864. doi: 10.18632/oncotarget.26974. eCollection 2019 Jun 11.

5.

HHLA2 is a novel immune checkpoint protein in pancreatic ductal adenocarcinoma and predicts post-surgical survival.

Yan H, Qiu W, Koehne de Gonzalez AK, Wei JS, Tu M, Xi CH, Yang YR, Peng YP, Tsai WY, Remotti HE, Miao Y, Su GH.

Cancer Lett. 2019 Feb 1;442:333-340. doi: 10.1016/j.canlet.2018.11.007. Epub 2018 Nov 14.

PMID:
30447255
6.

Pancreatic DCLK1+ cells originate distinctly from PDX1+ progenitors and contribute to the initiation of intraductal papillary mucinous neoplasm in mice.

Qiu W, Remotti HE, Tang SM, Wang E, Dobberteen L, Lee Youssof A, Lee JH, Cheung EC, Su GH.

Cancer Lett. 2018 Jun 1;423:71-79. doi: 10.1016/j.canlet.2018.03.009. Epub 2018 Mar 8.

7.

HER2 Heterogeneity in Gastroesophageal Cancer Detected by Testing Biopsy and Resection Specimens.

Fazlollahi L, Remotti HE, Iuga A, Yang HM, Lagana SM, Sepulveda AR.

Arch Pathol Lab Med. 2018 Apr;142(4):516-522. doi: 10.5858/arpa.2017-0039-OA. Epub 2017 Aug 7.

PMID:
28782986
8.

A Challenging Case of Hepatoblastoma Concomitant with Autosomal Recessive Polycystic Kidney Disease and Caroli Syndrome-Review of the Literature.

Kadakia N, Lobritto SJ, Ovchinsky N, Remotti HE, Yamashiro DJ, Emond JC, Martinez M.

Front Pediatr. 2017 Jun 7;5:114. doi: 10.3389/fped.2017.00114. eCollection 2017.

9.

Can diffusion-weighted imaging serve as a biomarker of fibrosis in pancreatic adenocarcinoma?

Hecht EM, Liu MZ, Prince MR, Jambawalikar S, Remotti HE, Weisberg SW, Garmon D, Lopez-Pintado S, Woo Y, Kluger MD, Chabot JA.

J Magn Reson Imaging. 2017 Aug;46(2):393-402. doi: 10.1002/jmri.25581. Epub 2017 Feb 2.

PMID:
28152252
10.

Identification of recurrent mutational events in anorectal melanoma.

Yang HM, Hsiao SJ, Schaeffer DF, Lai C, Remotti HE, Horst D, Mansukhani MM, Horst BA.

Mod Pathol. 2017 Feb;30(2):286-296. doi: 10.1038/modpathol.2016.179. Epub 2016 Oct 14.

11.

Crypt apoptotic body counts in normal ileal biopsies overlap with graft-versus-host disease and acute cellular rejection of small bowel allografts.

Sung D, Iuga AC, Kato T, Martinez M, Remotti HE, Lagana SM.

Hum Pathol. 2016 Oct;56:89-92. doi: 10.1016/j.humpath.2016.05.017. Epub 2016 May 28.

PMID:
27246175
12.

Loss of Activin Receptor Type 1B Accelerates Development of Intraductal Papillary Mucinous Neoplasms in Mice With Activated KRAS.

Qiu W, Tang SM, Lee S, Turk AT, Sireci AN, Qiu A, Rose C, Xie C, Kitajewski J, Wen HJ, Crawford HC, Sims PA, Hruban RH, Remotti HE, Su GH.

Gastroenterology. 2016 Jan;150(1):218-228.e12. doi: 10.1053/j.gastro.2015.09.013. Epub 2015 Sep 25.

13.

Smad4 loss synergizes with TGFα overexpression in promoting pancreatic metaplasia, PanIN development, and fibrosis.

Garcia-Carracedo D, Yu CC, Akhavan N, Fine SA, Schönleben F, Maehara N, Karg DC, Xie C, Qiu W, Fine RL, Remotti HE, Su GH.

PLoS One. 2015 Mar 24;10(3):e0120851. doi: 10.1371/journal.pone.0120851. eCollection 2015.

14.

Bile salt export pump: a sensitive and specific immunohistochemical marker of hepatocellular carcinoma.

Lagana SM, Salomao M, Remotti HE, Knisely AS, Moreira RK.

Histopathology. 2015 Mar;66(4):598-602. doi: 10.1111/his.12601. Epub 2015 Jan 23.

PMID:
25378077
15.

Loss of PTEN expression is associated with poor prognosis in patients with intraductal papillary mucinous neoplasms of the pancreas.

Garcia-Carracedo D, Turk AT, Fine SA, Akhavan N, Tweel BC, Parsons R, Chabot JA, Allendorf JD, Genkinger JM, Remotti HE, Su GH.

Clin Cancer Res. 2013 Dec 15;19(24):6830-41. doi: 10.1158/1078-0432.CCR-13-0624. Epub 2013 Oct 16.

16.

Gastric cancer and trastuzumab: first biologic therapy in gastric cancer.

Gunturu KS, Woo Y, Beaubier N, Remotti HE, Saif MW.

Ther Adv Med Oncol. 2013 Mar;5(2):143-51. doi: 10.1177/1758834012469429.

17.

Glutamine synthetase, heat shock protein-70, and glypican-3 in intrahepatic cholangiocarcinoma and tumors metastatic to liver.

Lagana SM, Moreira RK, Remotti HE, Bao F.

Appl Immunohistochem Mol Morphol. 2013 May;21(3):254-7. doi: 10.1097/PAI.0b013e3182642c9c.

PMID:
22914614
18.

Utility of an immunohistochemical panel consisting of glypican-3, heat-shock protein-70, and glutamine synthetase in the distinction of low-grade hepatocellular carcinoma from hepatocellular adenoma.

Lagana SM, Salomao M, Bao F, Moreira RK, Lefkowitch JH, Remotti HE.

Appl Immunohistochem Mol Morphol. 2013 Mar;21(2):170-6. doi: 10.1097/PAI.0b013e31825d527f.

PMID:
22914605
20.

Disruption of p16 and activation of Kras in pancreas increase ductal adenocarcinoma formation and metastasis in vivo.

Qiu W, Sahin F, Iacobuzio-Donahue CA, Garcia-Carracedo D, Wang WM, Kuo CY, Chen D, Arking DE, Lowy AM, Hruban RH, Remotti HE, Su GH.

Oncotarget. 2011 Nov;2(11):862-73.

21.

RAGE gene deletion inhibits the development and progression of ductal neoplasia and prolongs survival in a murine model of pancreatic cancer.

DiNorcia J, Lee MK, Moroziewicz DN, Winner M, Suman P, Bao F, Remotti HE, Zou YS, Yan SF, Qiu W, Su GH, Schmidt AM, Allendorf JD.

J Gastrointest Surg. 2012 Jan;16(1):104-12; discussion 112. doi: 10.1007/s11605-011-1754-9. Epub 2011 Nov 4.

22.

Molecular analysis of PIK3CA, BRAF, and RAS oncogenes in periampullary and ampullary adenomas and carcinomas.

Schönleben F, Qiu W, Allendorf JD, Chabot JA, Remotti HE, Su GH.

J Gastrointest Surg. 2009 Aug;13(8):1510-6. doi: 10.1007/s11605-009-0917-4. Epub 2009 May 14.

23.

Depth of resection using two different endoscopic mucosal resection techniques.

Abrams JA, Fedi P, Vakiani E, Hatefi D, Remotti HE, Lightdale CJ.

Endoscopy. 2008 May;40(5):395-9.

24.

Mutational analyses of multiple oncogenic pathways in intraductal papillary mucinous neoplasms of the pancreas.

Schönleben F, Allendorf JD, Qiu W, Li X, Ho DJ, Ciau NT, Fine RL, Chabot JA, Remotti HE, Su GH.

Pancreas. 2008 Mar;36(2):168-72. doi: 10.1097/MPA.0b013e318158a4d2.

25.

PIK3CA, KRAS, and BRAF mutations in intraductal papillary mucinous neoplasm/carcinoma (IPMN/C) of the pancreas.

Schönleben F, Qiu W, Remotti HE, Hohenberger W, Su GH.

Langenbecks Arch Surg. 2008 May;393(3):289-96. doi: 10.1007/s00423-008-0285-7. Epub 2008 Feb 21.

26.

BRAF and KRAS gene mutations in intraductal papillary mucinous neoplasm/carcinoma (IPMN/IPMC) of the pancreas.

Schönleben F, Qiu W, Bruckman KC, Ciau NT, Li X, Lauerman MH, Frucht H, Chabot JA, Allendorf JD, Remotti HE, Su GH.

Cancer Lett. 2007 May 8;249(2):242-8. Epub 2006 Nov 9.

27.

PIK3CA mutations in intraductal papillary mucinous neoplasm/carcinoma of the pancreas.

Schönleben F, Qiu W, Ciau NT, Ho DJ, Li X, Allendorf JD, Remotti HE, Su GH.

Clin Cancer Res. 2006 Jun 15;12(12):3851-5.

28.

Anorectal gastrointestinal stromal tumors: CT and MR imaging features with clinical and pathologic correlation.

Levy AD, Remotti HE, Thompson WM, Sobin LH, Miettinen M.

AJR Am J Roentgenol. 2003 Jun;180(6):1607-12.

PMID:
12760929
29.

Gastrointestinal stromal tumors: radiologic features with pathologic correlation.

Levy AD, Remotti HE, Thompson WM, Sobin LH, Miettinen M.

Radiographics. 2003 Mar-Apr;23(2):283-304, 456; quiz 532. Review.

PMID:
12640147
30.

Expression of KIT (CD117) in angiomyolipoma.

Makhlouf HR, Remotti HE, Ishak KG.

Am J Surg Pathol. 2002 Apr;26(4):493-7.

PMID:
11914628
31.

Objective ranking of fibrosis in standard histologic sections of human neonatal liver: applicability to alpha1-antitrypsin deficiency.

Moustafellos E, Illueca M, Remotti HE, Auld PA, Hanauske-Abel HM.

J Pediatr Gastroenterol Nutr. 2000 May;30(5):503-8.

PMID:
10817279
32.

Supplemental Content

Loading ...
Support Center